Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H, Kojima M, Kuwabara H, Kuroda M, Matsumoto K, Kanai C, Inada N, Owada K, Ochi K, Ono N, Benner S, Wakuda T, Kameno Y, Inoue J, Harada T, Tsuchiya K, Umemura K, Yamauchi A, Ogawa N, Kushima I, Ozaki N, Suyama S, Saito T, Uemura Y, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Kosaka H, Okada T. Yamasue H, et al. Among authors: owada k. Brain. 2022 Apr 18;145(2):490-499. doi: 10.1093/brain/awab291. Brain. 2022. PMID: 35067719 Clinical Trial.
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial.
Yamasue H, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Owada K, Yassin W, Kushima I, Benner S, Ogawa N, Eriguchi Y, Kawano N, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H. Yamasue H, et al. Among authors: owada k. Mol Psychiatry. 2020 Aug;25(8):1849-1858. doi: 10.1038/s41380-018-0097-2. Epub 2018 Jun 29. Mol Psychiatry. 2020. PMID: 29955161 Clinical Trial.
Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism.
Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, Matsumoto K, Kuwabara H, Mori D, Okamoto Y, Yoshimura Y, Kawakubo Y, Arioka Y, Kojima M, Yuhi T, Yassin W, Kushima I, Benner S, Ogawa N, Kawano N, Eriguchi Y, Uemura Y, Yamamoto M, Kano Y, Kasai K, Higashida H, Ozaki N, Kosaka H, Yamasue H. Owada K, et al. Brain. 2019 Jul 1;142(7):2127-2136. doi: 10.1093/brain/awz126. Brain. 2019. PMID: 31096266 Clinical Trial.
Paternal age contribution to brain white matter aberrations in autism spectrum disorder.
Yassin W, Kojima M, Owada K, Kuwabara H, Gonoi W, Aoki Y, Takao H, Natsubori T, Iwashiro N, Kasai K, Kano Y, Abe O, Yamasue H. Yassin W, et al. Among authors: owada k. Psychiatry Clin Neurosci. 2019 Oct;73(10):649-659. doi: 10.1111/pcn.12909. Epub 2019 Jul 30. Psychiatry Clin Neurosci. 2019. PMID: 31271249 Free article.
Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia.
Ikegame T, Bundo M, Okada N, Murata Y, Koike S, Sugawara H, Saito T, Ikeda M, Owada K, Fukunaga M, Yamashita F, Koshiyama D, Natsubori T, Iwashiro N, Asai T, Yoshikawa A, Nishimura F, Kawamura Y, Ishigooka J, Kakiuchi C, Sasaki T, Abe O, Hashimoto R, Iwata N, Yamasue H, Kato T, Kasai K, Iwamoto K. Ikegame T, et al. Among authors: owada k. Schizophr Bull. 2020 Dec 1;46(6):1577-1586. doi: 10.1093/schbul/sbaa075. Schizophr Bull. 2020. PMID: 32556264 Free PMC article.
221 results